Evidence map›Paper›PMID 40143163›Full record

ReviewPharmaceuticals (Basel, Switzerland)2025

Gallium-Labeled PET Radiopharmaceuticals in Cardiovascular Disease.

Matthieu Bailly, Anne Claire Dupont, Guillaume Domain, Diane Darsin-Bettinger, Maxime Courtehoux, Gilles Metrard, Alain Manrique, Jonathan Vigne

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Matthieu BaillyNuclear Medicine Department, CHU Orleans, 45100 Orléans, France.ORCID 0000-0001-6526-0813
Anne Claire DupontNuclear Medicine Department, CHU Tours, 37000 Tours, France.
Guillaume DomainCardiology Department, CHU Orleans, 45100 Orléans, France.ORCID 0000-0002-1244-734X
Diane Darsin-BettingerNuclear Medicine Department, CHU Orleans, 45100 Orléans, France.
Maxime CourtehouxNuclear Medicine Department, CHU Tours, 37000 Tours, France.
Gilles MetrardNuclear Medicine Department, CHU Orleans, 45100 Orléans, France.
Alain ManriqueNuclear Medicine Department, CHU Caen, 14000 Caen, France.ORCID 0000-0002-1578-0922
Jonathan VigneNuclear Medicine Department, CHU Caen, 14000 Caen, France.ORCID 0000-0002-6575-9224

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gallium-labeled positron emission tomography (PET) probes targeting activated fibroblasts or somatostatin receptor expression are frequently used for varying applications in oncology. With the widespread availability of

Indexed as

cardiovascularCXCR4DOTAFAPIgallium-labeled radiopharmaceuticalsmyocardial infarctionmyocarditissarcoidosis

Identifiers

PMID40143163
PMCPMC11945516

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.